Gene Therapy Market Share

Statistics for the 2023 & 2024 Gene Therapy market share, created by Mordor Intelligence™ Industry Reports. Gene Therapy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Gene Therapy Industry

The gene therapy market is highly competitive and consists of several significant players. Companies like Amgen Inc., Bluebird Bio, Gilead Sciences, Inc., Novartis AG, Orchard Therapeutics, Sibiono GeneTech Co. Ltd, Spark Therapeutics (Roche AG), and UniQure NV hold a substantial market share. They have various strategic alliances, such as collaborations and acquisitions, along with the launch of advanced products to secure their position in the global market.

Gene Therapy Market Leaders

  1. Gilead Sciences, Inc.

  2. Novartis

  3. Amgen Inc.

  4. Bluebird Bio

  5. Biogen Inc

*Disclaimer: Major Players sorted in no particular order

Gene Therapy Market Concentration

Gene Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)